ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 253 filers reported holding ARGENX SE in Q3 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $123,046,000 | -6.4% | 348,522 | +0.4% | 0.18% | -1.1% |
| Q2 2022 | $131,520,000 | +20.1% | 347,128 | -0.0% | 0.18% | +46.0% |
| Q1 2022 | $109,472,000 | -10.0% | 347,188 | +0.0% | 0.13% | -14.9% |
| Q4 2021 | $121,580,000 | +16.0% | 347,182 | +0.0% | 0.15% | +1.4% |
| Q3 2021 | $104,831,000 | -2.7% | 347,176 | -3.0% | 0.15% | +0.7% |
| Q2 2021 | $107,766,000 | +9.3% | 357,944 | -0.0% | 0.14% | -0.7% |
| Q1 2021 | $98,593,000 | -58.8% | 358,011 | -56.0% | 0.15% | -22.8% |
| Q4 2020 | $239,330,000 | +123.3% | 813,800 | +99.3% | 0.19% | -4.1% |
| Q3 2020 | $107,196,000 | +15.5% | 408,331 | -0.9% | 0.20% | +4.8% |
| Q2 2020 | $92,824,000 | +70.8% | 412,131 | -0.1% | 0.19% | +42.4% |
| Q1 2020 | $54,360,000 | -18.0% | 412,653 | -0.1% | 0.13% | +1.5% |
| Q4 2019 | $66,276,000 | +40.8% | 412,896 | -0.0% | 0.13% | +28.7% |
| Q3 2019 | $47,065,000 | -3.2% | 413,000 | +20.2% | 0.10% | -5.6% |
| Q2 2019 | $48,633,000 | +112.0% | 343,502 | +86.9% | 0.11% | +101.9% |
| Q1 2019 | $22,939,000 | – | 183,745 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |